MeiraGTx develops genetic medicines and manufactures them at its own sites in the United Kingdom and Ireland. It last closed at $8.46 on Nov 17, down 3.20% on the day.
Only 1 firm rated MGTX in the past 90 days, not enough for a consensus
Average 12-month target
$16.00
▲ 89.1% upside
Based on 1 analyst who set a price target on MGTX in the past 90 days. The average target is $16.00, with a high of $16.00 and a low of $16.00, compared with the last close of $8.46.
Low $16.00Avg $16.00High $16.00
Blue marker: last close $8.46
Highest target$16.00
Average target$16.00
Lowest target$16.00
Latest rating changes
Goldman SachsInitiated
Sep 24Hold$16
RBC CapitalTarget raised
Aug 14Buy$26 → $27
RBC CapitalMaintained
Jul 8Buy$26
HC Wainwright & Co.Reiterated
Jul 8Buy$20
Date
Firm
Action
Rating
Price target
Sep 24
Goldman Sachs
Initiated
Hold
$16
Aug 14
RBC Capital
Target raised
Buy
$26 → $27
Jul 8
RBC Capital
Maintained
Buy
$26
Jul 8
HC Wainwright & Co.
Reiterated
Buy
$20
Loading…
Technical Analysis
MGTX · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold
The stock is 10% below its 20 day and 24% below its 50 day average. It is 23% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 37), near oversold. The nearest support is the swing low (Nov 6) at $8.44, and the nearest resistance the Pivot at $8.47.
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityNormal, 6.4%/day
Key levels
$15.3552 week high+81.4%
$11.86100 day average+40.2%
$10.5150 day average+24.2%
$10.39200 day average+22.8%
$9.75Swing high (Nov 11)+15.2%
$9.3020 day average+9.9%
$8.66Pivot R1+2.4%
$8.47Pivot+0.1%
$8.46Last close
$8.44Swing low (Nov 6)−0.2%
$8.27Pivot S1−2.2%
$6.6252 week low−21.7%
Indicators
RSI (14)
37.17
Weak, oversold below 30
Neutral
MACD
-0.45
Above its signal line
Bullish
Stochastic
25.8
Middle of its range
Neutral
ADX (14)
29.1
Trending down
Williams %R
-89.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-185.3
Oversold below −100, overbought above 100
Oversold
Rate of change
−11.1%
Change over 10 sessions
Bearish
ATR (14)
$0.55
Typical daily range, 6.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, nearing oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 15.9%/day
Key levels
$15.3552 week high+81.4%
$11.86100 day average+40.2%
$10.5150 day average+24.2%
$10.39200 day average+22.8%
$9.75Swing high (Nov 11)+15.2%
$9.3020 day average+9.9%
$8.66Pivot R1+2.4%
$8.47Pivot+0.1%
$8.46Last close
$8.44Swing low (Nov 6)−0.2%
$8.27Pivot S1−2.2%
$6.6252 week low−21.7%
Indicators
RSI (14)
37.40
Weak, oversold below 30
Neutral
MACD
-0.43
Below its signal line
Bearish
Stochastic
7.0
Near the bottom of its range
Oversold
ADX (14)
28.3
Trending down
Williams %R
-97.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-124.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−33.9%
Change over 10 sessions
Bearish
ATR (14)
$1.34
Typical daily range, 15.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for MGTX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how MGTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow MGTX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How MGTX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MGTX is in one of them and how their past MGTX trades turned out.
MeiraGTx develops genetic medicines for inherited conditions and more common diseases, including conditions affecting the eye, salivary gland and central nervous system. The company makes its own viral vectors, plasmid DNA and quality control testing at manufacturing sites in London, United Kingdom and Shannon, Ireland. It is also developing a platform that uses oral small molecules to control gene expression in the body. Its headquarters are in New York, and it supplies commercial manufacturing to Johnson & Johnson Innovative Medicine.